Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study
Open Access
- 14 August 2023
- journal article
- research article
- Published by Springer Nature in Journal of Digital Imaging
- Vol. 36 (6) , 2554-2566
Abstract
This study aimed to explore the magnetic resonance imaging (MRI) features of dual-phenotype hepatocellular carcinoma (DPHCC) and their diagnostic value.The data of 208 patients with primary liver cancer were retrospectively analysed between January 2016 and June 2021. Based on the pathological diagnostic criteria, 27 patients were classified into the DPHCC group, 113 patients into the noncholangiocyte-phenotype hepatocellular carcinoma (NCPHCC) group, and 68 patients with intrahepatic cholangiocarcinoma (ICC) were classified into the ICC group. Two abdominal radiologists reviewed the preoperative MRI features by a double-blind method. The MRI features and key laboratory and clinical indicators were compared between the groups. The potentially valuable MRI features and key laboratory and clinical characteristics for predicting DPHCC were identified by univariate and multivariate analyses, and the odds ratios (ORs) were recorded. In multivariate analysis, tumour without capsule (P = 0.046, OR = 9.777), dynamic persistent enhancement (P = 0.006, OR = 46.941), and targetoid appearance on diffusion-weighted imaging (DWI) (P = 0.021, OR = 30.566) were independently significant factors in the detection of DPHCC compared to NCPHCC. Serum alpha-fetoprotein (AFP) > 20 µg/L (P = 0.036, OR = 67.097) and prevalence of hepatitis B virus (HBV) infection (P = 0.020, OR = 153.633) were independent significant factors in predicting DPHCC compared to ICC. The differences in other tumour marker levels and imaging features between the groups were not significant. In MR enhanced and diffusion imaging, tumour without capsule, persistent enhancement and DWI targetoid findings, combined with AFP > 20 µg/L and HBV infection-positive laboratory results, can help to diagnose DPHCC and differentiate it from NCPHCC and ICC. These results suggest that clinical, laboratory and MRI features should be integrated to construct an AI diagnostic model for DPHCC.Keywords
Funding Information
- Science and Technology Program of Zhejiang Province (2021449207)
This publication has 24 references indexed in Scilit:
- CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I. Development, Growth, and Spread: Key Pathologic and Imaging AspectsRadiology, 2014
- Keratin 19: a key role player in the invasion of human hepatocellular carcinomasGut, 2013
- Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRIEuropean Journal of Radiology, 2013
- Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinomaAbdominal Radiology, 2012
- Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancersWorld Journal of Gastroenterology, 2012
- Hepatocellular Carcinoma Expressing Cholangiocyte Phenotype Is a Novel Subtype with Highly Aggressive BehaviorAnnals of Surgical Oncology, 2011
- Recent advances in the natural history of hepatocellular carcinomaCarcinogenesis, 2008
- Histologic Characteristics and Prognostic Significance in Small Hepatocellular Carcinoma With Biliary DifferentiationAmerican Journal of Surgical Pathology, 2007
- Iron‐containing nodules of cirrhosisNMR in Biomedicine, 2004
- Cell motility mediated by rho and rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinomaHepatology, 1999